Learn how a quality measure evolves from quality improvement to Centers for Medicare & Medicaid Services (CMS) accountability programs through a real-world cholesterol measure case study. Drawing on more than 20 years of measure development experience, the American Heart Association will share practical insights into developing, testing and advancing quality measures for broader adoption.

Using the cholesterol measure as an example, attendees will follow its evolution from the identification of a clinical quality gap through implementation in quality improvement initiatives and ultimately accountability programs. The session will highlight how the measure was incorporated into the Association's Outpace Registry and leveraged in the integrated ASCVD initiative, demonstrating how measures can drive improvement while generating evidence for broader use. We’ll conclude with the steps to navigate the refinement process and key considerations for quality leaders, registry participants, health system professionals and organizations seeking to advance measures into accountability and value-based care programs.

Sponsored by: